Did the AI tells reach medicine? 1.4 million PubMed abstracts, 2015 to 2026

SGR-024, conducted 2026-10-29. Analyst: Jack Stovell, founder, ScriptGrain.

Question: Did the words that moved in arXiv abstracts after ChatGPT (old tells such as "delve" and "pivotal", then a different set from 2025) also move in PubMed abstracts, and how does that compare with what Kobak and colleagues found for 2024?

Summary

Background. SGR-008 found that in arXiv abstracts the words once called signs of ChatGPT, such as "delve" and "pivotal", rose in 2024 and then fell, while a different set of words rose in 2025 and 2026. Kobak and colleagues had already shown excess vocabulary in 2024 PubMed abstracts, and later work estimates that a large majority of recent biomedical papers carry language-model traces. This study asks whether the arXiv pattern also holds in medicine and biology, and checks our method against theirs.

What we did. We fixed six hypotheses and two checks against Kobak et al. in public before the full measurement. We took a fixed 10% sample of PubMed records by a hash of the PubMed identifier, kept 1,383,539 English journal-article abstracts of at least 50 words entered from January 2015 to September 2026, and measured the same three word sets as SGR-008 (twelve old tells, twelve new words, five control words), the share of abstracts containing any word of each set. We then selected excess words in each year on odd months, scored them on even months, labelled each as style or content by fixed rules, and computed a lower bound on the share of abstracts affected. Confidence intervals come from resampling 13,114 journals.

What we found. Old tells: 4.73% of abstracts in 2020 to November 2022, 11.55% in 2024 and 8.22% in 2026. New words: 1.33%, 1.81% and 5.08%. The hypothesis that the old tells rose and then fell (H1) was supported; that the new words rose, doubling in at least six of eight subject groups (H2), supported; and that the new words overtook the old in 2025 or 2026 (H3), not supported. In 2026H2 (July to September 2026) the old tells were in 6.71% of abstracts and the new words in 5.61%. Unlike in arXiv, where the old tells fell below their pre-ChatGPT level, in PubMed they were still above it in 2026. So SGR-008 partly replicates in medicine. Our lower bound for 2024 from the 2024 style words was 29.83% (26.44 to 32.70), above the range we set around Kobak et al.'s 13.5% estimate (our check C1 was not supported), and the same method gives bounds of up to 8.72% in placebo years before ChatGPT.

What it means. A shift in the words used in abstracts is a shift in how abstracts read. It does not show who or what wrote them, and the lower bounds count only abstracts using the specific words we selected.

Key numbers

Sample

A fixed 10% sample of PubMed records (those whose SHA-1 of "sgr-024:" plus the PubMed identifier falls in the lowest tenth), read from the NCBI annual baseline and daily update files, latest version of each record, with 1,383,539 abstracts from 13,114 journals meeting the rules below. Entry dates run from January 2015 to September 2026.

Method

Pre-registration: the six hypotheses, two checks against Kobak et al., word sets, thresholds and analysis were committed to the public repository before the full measurement (docs/research/sgr-024-preregistration.md). The script was tested on a 4% pilot; the pilot results are not reported.

Sampling: a fixed hash of the PubMed identifier picks 10% of records, so the sample is the same whenever it is drawn. Records come from NCBI's annual baseline and daily update files; the latest version of each record is used and deleted records are dropped.

Measures: tokens are lowercase runs of letters and hyphens of three or more characters. A set's share is the percentage of abstracts with at least one of its words. No language model is used.

Hypotheses: H1 old tells rise from 2020 to 2022 to 2024 then fall by 2026; H2 new words rise, at least doubling in six of eight subject groups; H3 the new words overtake the old in a half-year from 2025H1 to 2026H2. All are judged on 95% cluster-bootstrap intervals over journals.

Excess words: for each year, a word's expected share is its 2022 share plus the 2021 to 2022 change carried forward. Words are selected on odd entry months and scored on even months. Selected words are labelled style or content by fixed rules (Kobak et al.'s published labels first, then SGR-008's, then an AI-topic rule, then breadth across subject groups); no language model labels anything.

Subject groups: each journal is assigned a group from MeSH major topics of its records entered before December 2022.

Variables measured

What each measure means

Old tells
Twelve words fixed in SGR-008 before any data: innovative, utilized, advancements, pivotal, facilitates, firstly, tackle, showcasing, underscores, delve, delves, intricate. The share is the percentage of abstracts containing at least one of them.
New words
Twelve words fixed in SGR-008 from a separate sample: underexplored, grounded, aligns, synthesizes, replaces, leaving, recovers, expose, structurally, reproducible, treats, vanishes. Same measure.
Control words
Five common words, however, results, using, show and method, to check that the sample did not drift.
Entry date
The date PubMed first received the record (the entrez date). Months are counted from it; publication date is a sensitivity analysis.
Excess words and the lower bound
As in Kobak et al. and SGR-008: a word is excess in a year if its share exceeds the share projected from 2021 and 2022. Words are selected on odd months and scored on even months. The lower bound is the share of abstracts containing at least one selected style word, beyond the share expected without a rise.
95% interval
From 2,000 resamples that draw whole journals with replacement (seed 20261029).

Findings

What this study does not show

Two word sets by half-year

Line chart of the share of PubMed abstracts containing an old tell or a new word, by half-year of entry from 2015 to 2026. Old tells 4.73% in 2020 to 2022, 11.55% in 2024, 8.22% in 2026; new words 1.33%, 1.81%, 5.08%.
Source: ScriptGrain SGR-024, CC BY 4.0.

Lower bound on abstracts touched by style words

Chart of the lower bound on the share of abstracts using selected style words, 2023 to 2026. Union of the 2024 and 2026 lists: 30.8% in 2024 and 67.8% in 2026.
Source: ScriptGrain SGR-024, CC BY 4.0.

Pre-registered hypotheses and results

HypothesisResultMeasuredPass rule
H1 old tells rose then fellSupported+6.82 then −3.33 pointsRise lower end above 0, fall upper end below 0
H2 new words rose in most groupsSupported8 of 8 groups doubledBoth pooled intervals above 0, at least 6 of 8 groups at least 2 times
H3 new words overtook oldNot supportedno crossoverCrossover in 2025H1 to 2026H2
H4 sentence length unchangedSupported−0.49 words90% interval within plus or minus 1 word
H5 style words changedSupportedJaccard 0.299Below 0.5
H6 matches Kobak et al.'s listSupported45 of 50At least 30 of 50
C1 bound near their 13.5%Not supported29.83%Lower end above 0 and point between 6.75% and 27%
C2 counts match theirsSupported100% in windowAt least 80% of word-years in 0.8 to 1.4

PubMed and arXiv side by side

Percentage of abstracts containing at least one word of each set. The arXiv column is SGR-008's published result; the two corpora differ in field, length and who writes in them, so the comparison is of pattern, not of level.

Set and periodPubMed (this study)95% intervalarXiv (SGR-008)
Old tells, 2020 to Nov 20224.734.57 to 4.874.54
Old tells, 202411.5511.04 to 12.0611.85
Old tells, Jan to Sep 20268.227.94 to 8.493.03
New words, 2020 to Nov 20221.331.27 to 1.391.90
New words, 20241.811.72 to 1.913.31
New words, Jan to Sep 20265.084.89 to 5.2912.39
Control words, 2020 to Nov 202265.5964.81 to 66.4273.48
Control words, Jan to Sep 202667.3566.40 to 68.4172.64

By subject group

Journals are grouped by the MeSH major topics of their records entered before December 2022; journals without a clear majority are in General and those with too few records are Unclassified. Ratio is the new-word share in 2026 over the share in 2020 to November 2022.

Three of the eight groups are small (Cancer: 12 journals; Heart, blood vessels and metabolism: 21 journals; Infection and immunity: 17 journals), so their ratios are very uncertain and the 95% intervals reach zero. The rule was set on the point ratio, as pre-registered; leaving the small groups aside, 5 of the 5 groups with 30 or more journals at least doubled, fewer than the six the rule asks for, so the group condition rests partly on the small groups.

GroupJournalsNew words, baseline %New words, 2026 %Ratio (95% interval)Old tells 2024 %
Cancer120.322.638.26 (0.00 to 17.62)9.38
Heart, blood vessels and metabolism210.422.175.18 (0.00 to 29.89)8.68
Brain and mind3971.455.473.77 (2.98 to 4.85)7.88
Infection and immunity170.190.965.09 (0.00 to 23.68)2.27
Other body systems and surgery3611.113.653.27 (2.68 to 4.02)6.96
Health services, public health and society8671.966.953.55 (3.11 to 4.07)9.45
Methods and techniques2201.935.302.75 (2.33 to 3.25)14.87
Molecular and cell biology, chemicals and drugs1,4091.505.303.53 (3.22 to 3.85)12.91
General or mixed journals1,8521.014.104.06 (3.60 to 4.53)9.84
Unclassified (too little MeSH indexing)7,9581.205.334.44 (3.99 to 4.93)12.55

Lower bounds and the placebo

Lower bound on the percentage of abstracts using at least one selected style word, beyond what the 2021 and 2022 trend projects, with 95% intervals over journals. The placebo rows apply the same method to years before ChatGPT, using a 2016 to 2017 trend; a bound near zero there is the method behaving.

Word listYearLower bound %95% interval
2024 style words20238.746.04 to 11.23
2024 style words202429.8326.44 to 32.70
2024 style words202548.9345.37 to 51.83
2024 style words202649.4745.12 to 53.06
2026 style words20235.281.75 to 8.34
2026 style words202424.7020.38 to 28.32
2026 style words202547.6043.30 to 51.08
2026 style words202666.0662.36 to 68.80
Union of both lists20237.633.68 to 11.31
Union of both lists202430.7826.13 to 35.22
Union of both lists202553.1748.43 to 57.47
Union of both lists202667.7663.45 to 71.26
Placebo A: 2024 list20181.35−1.25 to 3.67
Placebo A: 2024 list20191.62−2.57 to 5.24
Placebo A: 2024 list20202.47−3.47 to 7.18
Placebo A: 2024 list20214.72−2.96 to 10.60
Placebo A: 2026 list20182.17−0.77 to 3.97
Placebo A: 2026 list20192.32−2.62 to 4.33
Placebo A: 2026 list20204.40−2.15 to 6.31
Placebo A: 2026 list20218.720.59 to 10.51
Placebo B: words reselected in 20192019-4.73−15.02 to 4.58
Placebo B: words reselected in 202120218.58−4.22 to 19.05

Sensitivity analyses

The same set shares under different choices. Each row repeats the main analysis with one change; intervals are from 1,000 or fewer journal resamples.

With the baseline moved to 2018 and 2019 (before COVID-19), the old tells were in 4.02% of abstracts (3.89 to 4.17) and the new words in 1.42% (1.35 to 1.50), close to the main baseline. 30.6% of the sampled records entered before December 2022 were last revised after November 2022; PubMed revisions are usually to metadata, so no record was excluded for it. The within-journal row uses 636 journals.

ChoiceAbstracts (baseline, 2024, 2026)Old tells: 2024 minus baseline (points)New words: 2026 minus baseline (points)
Main analysis374,802, 133,732, 113,852+6.82 (6.36 to 7.29)+3.75 (3.57 to 3.95)
Months by publication date374,548, 133,577, 110,869+6.93 (6.46 to 7.38)+3.78 (3.57 to 3.97)
Retracted papers dropped373,532, 133,559, 113,839+6.81 (6.34 to 7.28)+3.75 (3.54 to 3.94)
Structured abstracts only129,132, 49,231, 46,432+5.18 (4.79 to 5.53)+2.91 (2.68 to 3.13)
Unstructured abstracts only245,670, 84,501, 67,420+7.82 (7.22 to 8.40)+4.36 (4.10 to 4.65)
Journals with 30+ records in baseline and 2026179,891, 69,295, 61,542+7.95 (7.30 to 8.62)+3.89 (3.58 to 4.21)
Each journal weighted equally374,802, 133,732, 113,852+5.06 (4.61 to 5.47)+3.37 (3.05 to 3.69)

Sentence shape and other text features

Means over abstracts for the measured features, with the 2026 minus baseline difference and its 95% interval.

Feature2020 to Nov 2022202420262026 minus baseline (95% interval)
Words per sentence22.7422.5622.25−0.49 (−0.59 to −0.40)
Sentence length variance89.1885.0478.67−10.51 (−12.04 to −8.91)
Commas per sentence1.191.291.45+0.26 (0.25 to 0.27)
Semicolons per 1,000 words2.251.972.60+0.34 (0.26 to 0.43)
"We" as a share of I, we and you0.960.950.95−0.01 (−0.01 to −0.01)
Long words as a share of all words0.310.330.37+0.06 (0.05 to 0.06)
AI-tell scanner hits per 1,000 words1.701.841.49−0.21 (−0.25 to −0.17)
Em dashes per 1,000 words0.000.000.02+0.01 (0.01 to 0.02)
Sentence length variation (burstiness)0.390.380.37−0.01 (−0.02 to −0.01)
Words per abstract216.70223.19228.29+11.59 (9.86 to 13.20)

How abstracts and journals changed

YearAbstractsStructured %Retracted %20 largest journals %
201587,69332.570.127.16
201691,10032.410.128.04
201794,16532.250.169.05
201898,10834.050.199.06
2019103,84734.260.2010.06
2020120,96034.940.2110.59
2021130,86834.490.2511.78
2022133,84834.040.5212.84
2023128,54535.440.1614.20
2024133,73236.810.1314.83
2025146,82139.190.0713.69
2026113,85240.780.0112.00

Limitations

Competing interests

ScriptGrain sells writing-voice measurement and the analyst builds it; a story that medicine is full of machine-written text could suit the product. The hypotheses, word sets, thresholds and pass and fail rules were committed to the public repository before the full measurement, every hypothesis is reported whichever way it came out, and the data and scripts are public.

Reproducing this

Data

Released under CC BY 4.0: free to reuse, including commercially, with credit to ScriptGrain and a link to this page.

Citations

How to cite

ScriptGrain (2026). Did the AI tells reach medicine? 1.4 million PubMed abstracts, 2015 to 2026 (Study SGR-024, conducted 29 October 2026). Dataset licensed CC BY 4.0. Derived from PubMed records (U.S. National Library of Medicine, public domain; individual abstracts remain the property of their publishers). https://scriptgrain.com/research/did-the-ai-tells-reach-medicine

About the analyst

Jack Stovell has worked in finance and data for more than twelve years, building management reporting, forecasting and profitability models for advertising agencies and tech scale-ups, from SQL and Power BI reporting to board-level analysis. Since 2016 he has run Adapt Progress Evolve, an applied AI studio, where he builds and operates AI systems and data products: ScriptGrain's measurement of writing voice across 45 attributes, UK Spend, which brings 16.7 million rows of UK council spending into one queryable dataset, and more than thirty AI agents running in production. He designs ScriptGrain's studies and is accountable for every number in them.

More research